UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002111
Receipt number R000002574
Scientific Title Effect of proton pump inhibitor pretreatment for eradication of helicobacter pylori.
Date of disclosure of the study information 2009/07/01
Last modified on 2016/03/09 16:33:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of proton pump inhibitor pretreatment for eradication of helicobacter pylori.

Acronym

Effect of proton pump inhibitor pretreatment for eradication of helicobacter pylori.

Scientific Title

Effect of proton pump inhibitor pretreatment for eradication of helicobacter pylori.

Scientific Title:Acronym

Effect of proton pump inhibitor pretreatment for eradication of helicobacter pylori.

Region

Japan


Condition

Condition

Patient with gastrointestinal ulcer and helicobacter pylori positive.

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Some study show that proton pump inhibitor pretreatment for eradication of helicobacter pylori does not affect the result. The proton pump inhibitor pretreatment for eradication of helicobacter pylori is useful for improvement of subjective symptoms. We study whether the proton pump inhibitor pretreatment for eradication of helicobacter pylori affect quality of life.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Self questionnaire.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Omeplazole 20mg pre eradication

Interventions/Control_2

Omeplazole 20mg post eradication

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient who fills everything the following
1) Helicobacter pylori-positive patient has ulcer.
2) Patient of 20 years or more
3) Patient who gives written informed consent

Key exclusion criteria

The patient who collides with either the following assumes that it doesn't put it in to the examination
1) Drug allergy
2) Subjects with malignancy
3)Others

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsushi Nakajima

Organization

Yokohama City University Graduate School of Medicine

Division name

Gastroenterology Division

Zip code


Address

3-9 Fuku-ura, Kanagawa-ku, Yokohama, Japan

TEL

045-787-2640

Email

nakajima-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masahiko Inamori

Organization

Yokohama City University Graduate School of Medicine

Division name

Gastroenterology Division

Zip code


Address

3-9 Fuku-ura, Kanagawa-ku, Yokohama, Japan

TEL

045-787-2640

Homepage URL


Email

inamorim@med.yokohama-cu.ac.jp


Sponsor or person

Institute

Gastroenterology Division, Yokohama City University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 09 Month 01 Day

Last follow-up date

2014 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 06 Month 23 Day

Last modified on

2016 Year 03 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002574


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name